Pacira Pharmaceuticals reported $109.42M in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US USD 12.73M 2.43M
Amerisourcebergen ABC:US USD 3.39B 353.96M
Astellas Pharma 4503:JP JPY 361.07B 48.06B
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Cara Therapeutics CARA:US USD 42.81M 3.91M
Coherus Biosciences CHRS:US USD 286.8M 11.32M
Depomed DEPO:US USD 64.83M 12.56M
Endo International Ordinary Shares ENDP:US USD 1.05B 137.68M
Heron Therapeutics HRTX:US USD 50.44M 1.83M
Horizon Pharma HZNP:US USD 2.13B 237.96M
Ironwood Pharmaceuticals IRWD:US USD 574.19M 69.82M
Jazz Pharmaceuticals JAZZ:US USD 482.67M 191.74M
Lannett LCI:US USD 77.92M 9.94M
Ligand Pharmaceuticals LGND:US USD 121.41M 116.13M
Nektar Therapeutics NKTR:US USD 105.76M 28.21M
Omeros OMER:US USD 145.53M 131.4M
Pacira Pharmaceuticals PCRX:US USD 109.42M 12.64M
Perrigo Ordinary Shares PRGO:US USD 468.7M 16.6M
Revance Therapeutics RVNC:US USD 104.49M 35.07M
Supernus Pharmaceuticals SUPN:US USD 111.49M 61.94M
Teva Pharmaceutical TEVA:IT USD 2.22B 167M
Xeris Pharmaceuticals Inc XERS:US USD 84.11M 11.23M
Zoetis ZTS:US USD 2.5B 145M